Meeder Asset Management Inc Assertio Holdings, Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.54 - $6.66 $12,609 - $23,722	-3,562 Reduced 84.31%	663 $4,000
Q4 2022 Feb 14, 2023	BUY	$2.11 - $4.3 $565 - $1,152	268 Added 6.77%	4,225 $18,000
Q2 2022 Aug 08, 2022	SELL	$1.88 - $3.42 $500 - $909	-266 Reduced 6.3%	3,957 $12,000
Q1 2022 May 10, 2022	BUY	$2.06 - $3.0 $8,699 - $12,669	4,223 New	4,223 $12,000
Q4 2021 Feb 11, 2022	SELL	$0.86 - $2.3 $5,257 - $14,059	-6,113 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$1.48 - $2.88 $9,047 - $17,605	6,113 New	6,113 $10,000

114

37.2M

755K

39.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $58.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.